173 related articles for article (PubMed ID: 31472904)
1. Biliary Tract and Primary Liver Tumors: Who, What, and Why?
Hemming AW
Surg Oncol Clin N Am; 2019 Oct; 28(4):519-538. PubMed ID: 31472904
[TBL] [Abstract][Full Text] [Related]
2. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001.
West J; Wood H; Logan RF; Quinn M; Aithal GP
Br J Cancer; 2006 Jun; 94(11):1751-8. PubMed ID: 16736026
[TBL] [Abstract][Full Text] [Related]
3. Staging of Biliary and Primary Liver Tumors: Current Recommendations and Workup.
Krampitz GW; Aloia TA
Surg Oncol Clin N Am; 2019 Oct; 28(4):663-683. PubMed ID: 31472912
[TBL] [Abstract][Full Text] [Related]
4. Biliary tract cancers: epidemiology, molecular pathogenesis and genetic risk associations.
Marcano-Bonilla L; Mohamed EA; Mounajjed T; Roberts LR
Chin Clin Oncol; 2016 Oct; 5(5):61. PubMed ID: 27829275
[TBL] [Abstract][Full Text] [Related]
5. Biliary tract cancers in Olmsted County, Minnesota, 1976-2008.
Yang JD; Kim B; Sanderson SO; Sauver JS; Yawn BP; Larson JJ; Therneau TM; Roberts LR; Gores GJ; Kim WR
Am J Gastroenterol; 2012 Aug; 107(8):1256-62. PubMed ID: 22751468
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and risk factors of biliary tract and primary liver tumors.
Augustine MM; Fong Y
Surg Oncol Clin N Am; 2014 Apr; 23(2):171-88. PubMed ID: 24560105
[TBL] [Abstract][Full Text] [Related]
7. Obesity and hepatocellular carcinoma: hype and reality.
El-Serag HB; Kanwal F
Hepatology; 2014 Sep; 60(3):779-81. PubMed ID: 24753107
[No Abstract] [Full Text] [Related]
8. Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.
Aleksandrova K; Boeing H; Nöthlings U; Jenab M; Fedirko V; Kaaks R; Lukanova A; Trichopoulou A; Trichopoulos D; Boffetta P; Trepo E; Westhpal S; Duarte-Salles T; Stepien M; Overvad K; Tjønneland A; Halkjaer J; Boutron-Ruault MC; Dossus L; Racine A; Lagiou P; Bamia C; Benetou V; Agnoli C; Palli D; Panico S; Tumino R; Vineis P; Bueno-de-Mesquita B; Peeters PH; Gram IT; Lund E; Weiderpass E; Quirós JR; Agudo A; Sánchez MJ; Gavrila D; Barricarte A; Dorronsoro M; Ohlsson B; Lindkvist B; Johansson A; Sund M; Khaw KT; Wareham N; Travis RC; Riboli E; Pischon T
Hepatology; 2014 Sep; 60(3):858-71. PubMed ID: 24443059
[TBL] [Abstract][Full Text] [Related]
9. Biliary Tract Cancer: Epidemiology, Radiotherapy, and Molecular Profiling.
Bridgewater JA; Goodman KA; Kalyan A; Mulcahy MF
Am Soc Clin Oncol Educ Book; 2016; 35():e194-203. PubMed ID: 27249723
[TBL] [Abstract][Full Text] [Related]
10. Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults.
McGee EE; Castro FA; Engels EA; Freedman ND; Pfeiffer RM; Nogueira L; Stolzenberg-Solomon R; McGlynn KA; Hemminki K; Koshiol J
Int J Cancer; 2019 Feb; 144(4):707-717. PubMed ID: 30155920
[TBL] [Abstract][Full Text] [Related]
11. Risk of hepatobiliary cancer after solid organ transplant in the United States.
Koshiol J; Pawlish K; Goodman MT; McGlynn KA; Engels EA
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1541-9.e3. PubMed ID: 24362053
[TBL] [Abstract][Full Text] [Related]
12. Reply: To PMID 24443059.
Aleksandrova K; Pischon T
Hepatology; 2015 Jul; 62(1):320-1. PubMed ID: 25475540
[No Abstract] [Full Text] [Related]
13. Biliary tract cancers in Cote-d'Or (France): incidence and natural history.
Renard P; Boutron MC; Faivre J; Milan C; Bedenne L; Hillon P; Klepping C
J Epidemiol Community Health; 1987 Dec; 41(4):344-8. PubMed ID: 3455429
[TBL] [Abstract][Full Text] [Related]
14. Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.
Segura-López FK; Güitrón-Cantú A; Torres J
World J Gastroenterol; 2015 Feb; 21(5):1414-23. PubMed ID: 25663761
[TBL] [Abstract][Full Text] [Related]
15. Molecular Characteristics of Biliary Tract and Primary Liver Tumors.
Tsai S; Gamblin TC
Surg Oncol Clin N Am; 2019 Oct; 28(4):685-693. PubMed ID: 31472913
[TBL] [Abstract][Full Text] [Related]
16. Issue in statistical strategy in case-control study.
Li XY; Bai MJ; Chen LJ; Xu JL; Lin ZH; Li X; Xing YF
Hepatology; 2015 Jul; 62(1):320. PubMed ID: 25477185
[No Abstract] [Full Text] [Related]
17. Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged.
Alabraba E; Joshi H; Bird N; Griffin R; Sturgess R; Stern N; Sieberhagen C; Cross T; Camenzuli A; Davis R; Evans J; O'Grady E; Palmer D; Diaz-Nieto R; Fenwick S; Poston G; Malik H
Eur J Surg Oncol; 2019 Sep; 45(9):1660-1667. PubMed ID: 31014988
[TBL] [Abstract][Full Text] [Related]
18. Biliary tract malignancies: a population-based study on incidence, prognosis and management of patients.
Juliusson G; Jonasson JG; Jonsdottir SB; Garcia HG; Olafsdottir E; Möller PH; Björnsson ES
Scand J Gastroenterol; 2016 Dec; 51(12):1520-1525. PubMed ID: 27553174
[TBL] [Abstract][Full Text] [Related]
19. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics of multiple primary cancers in hepatobiliary and pancreas malignancies.
Nanashima A; Kondo H; Nakashima M; Abo T; Arai J; Ishii M; Hidaka S; Kunizaki M; To K; Takeshita H; Yamasaki N; Tsuchiya T; Nagayasu T
Anticancer Res; 2015 Feb; 35(2):1073-83. PubMed ID: 25667496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
